Literature DB >> 33542258

Elevated preoptic brain activity in zebrafish glial glycine transporter mutants is linked to lethargy-like behaviors and delayed emergence from anesthesia.

Michael J Venincasa1, Owen Randlett2,3, Sureni H Sumathipala1, Richard Bindernagel1, Matthew J Stark1, Qing Yan1, Steven A Sloan1,4, Elena Buglo1,5,6, Qing Cheng Meng7, Florian Engert2, Stephan Züchner5,6, Max B Kelz7,8,9,10, Sheyum Syed11, Julia E Dallman12.   

Abstract

Delayed emergence from anesthesia was previously reported in a case study of a child with Glycine Encephalopathy. To investigate the neural basis of this delayed emergence, we developed a zebrafish glial glycine transporter (glyt1 - / -) mutant model. We compared locomotor behaviors; dose-response curves for tricaine, ketamine, and 2,6-diisopropylphenol (propofol); time to emergence from these anesthetics; and time to emergence from propofol after craniotomy in glyt1-/- mutants and their siblings. To identify differentially active brain regions in glyt1-/- mutants, we used pERK immunohistochemistry as a proxy for brain-wide neuronal activity. We show that glyt1-/- mutants initiated normal bouts of movement less frequently indicating lethargy-like behaviors. Despite similar anesthesia dose-response curves, glyt1-/- mutants took over twice as long as their siblings to emerge from ketamine or propofol, mimicking findings from the human case study. Reducing glycine levels rescued timely emergence in glyt1-/- mutants, pointing to a causal role for elevated glycine. Brain-wide pERK staining showed elevated activity in hypnotic brain regions in glyt1-/- mutants under baseline conditions and a delay in sensorimotor integration during emergence from anesthesia. Our study links elevated activity in preoptic brain regions and reduced sensorimotor integration to lethargy-like behaviors and delayed emergence from propofol in glyt1-/- mutants.

Entities:  

Year:  2021        PMID: 33542258     DOI: 10.1038/s41598-021-82342-w

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  47 in total

1.  Plasma orexin A increases at emergence from sevoflurane-fentanyl anesthesia in patients undergoing ophthalmologic surgery.

Authors:  Tetsuya Kushikata; Hitoshi Yoshida; Mihoko Kudo; Tsuyoshi Kudo; Kazuyoshi Hirota
Journal:  Neurosci Lett       Date:  2010-07-22       Impact factor: 3.046

2.  Glycine encephalopathy and delayed emergence from anesthesia.

Authors:  Chih-Min Liu; Shou-Zen Fan
Journal:  Anesth Analg       Date:  2006-12       Impact factor: 5.108

3.  An essential role for orexins in emergence from general anesthesia.

Authors:  Max B Kelz; Yi Sun; Jingqiu Chen; Qing Cheng Meng; Jason T Moore; Sigrid C Veasey; Shelley Dixon; Marcus Thornton; Hiromasa Funato; Masashi Yanagisawa
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-14       Impact factor: 11.205

4.  Loss of Glycine Transporter 1 Causes a Subtype of Glycine Encephalopathy with Arthrogryposis and Mildly Elevated Cerebrospinal Fluid Glycine.

Authors:  Alina Kurolap; Anja Armbruster; Tova Hershkovitz; Katharina Hauf; Adi Mory; Tamar Paperna; Ewald Hannappel; Galit Tal; Yusif Nijem; Ella Sella; Muhammad Mahajnah; Anat Ilivitzki; Dov Hershkovitz; Nina Ekhilevitch; Hanna Mandel; Volker Eulenburg; Hagit N Baris
Journal:  Am J Hum Genet       Date:  2016-10-20       Impact factor: 11.025

5.  Effects of orexin-A on propofol anesthesia in rats.

Authors:  Tetsuro Shirasaka; Tetsu Yonaha; Shin Onizuka; Isao Tsuneyoshi
Journal:  J Anesth       Date:  2010-12-10       Impact factor: 2.078

6.  Mild glycine encephalopathy (NKH) in a large kindred due to a silent exonic GLDC splice mutation.

Authors:  H Flusser; S H Korman; K Sato; Y Matsubara; A Galil; S Kure
Journal:  Neurology       Date:  2005-04-26       Impact factor: 9.910

7.  Persistent NKH with transient or absent symptoms and a homozygous GLDC mutation.

Authors:  Stanley H Korman; Avihu Boneh; Akiko Ichinohe; Kanako Kojima; Kenichi Sato; Zivanit Ergaz; John M Gomori; Alisa Gutman; Shigeo Kure
Journal:  Ann Neurol       Date:  2004-07       Impact factor: 10.422

Review 8.  Clinical, ethical and legal considerations in the treatment of newborns with non-ketotic hyperglycinaemia.

Authors:  A Boneh; S Allan; D Mendelson; M Spriggs; L H Gillam; S H Korman
Journal:  Mol Genet Metab       Date:  2008-04-18       Impact factor: 4.797

9.  Orexin-A facilitates emergence from propofol anesthesia in the rat.

Authors:  Li-Na Zhang; Zhao-Ju Li; Li Tong; Chao Guo; Ji-Yuan Niu; Wu-Gang Hou; Hai-Long Dong
Journal:  Anesth Analg       Date:  2012-07-13       Impact factor: 5.108

10.  Mutation in SLC6A9 encoding a glycine transporter causes a novel form of non-ketotic hyperglycinemia in humans.

Authors:  Majid Alfadhel; Marwan Nashabat; Hanan Al Qahtani; Ahmed Alfares; Fuad Al Mutairi; Hesham Al Shaalan; Ganka V Douglas; Klaas Wierenga; Jane Juusola; Muhammad Talal Alrifai; Stefan T Arold; Fowzan Alkuraya; Qais Abu Ali
Journal:  Hum Genet       Date:  2016-08-01       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.